UroGen CFO Degnan files Form 144 for 2,202 URGN shares
UroGen Pharma CFO Chris Degnan filed a Form 144 with the SEC indicating an intention to sell 2,202 restricted URGN shares, registered on 10/9/2026, with an approximate sale date of 10/8/2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.